CEO of Botox maker vows to limit price hikes

Brent Saunders, CEO of drugmaker Allergan, in a blog post criticized a recent spate of controversial drug price hikes.

He didn't mention any drugmaker's pricing decisions by name, but he said, "I understand the public outcry and add my voice to the condemnation of these behaviors."

Saunders pledged Allergan's price increases - such as for its drug Botox - would be less than 10 percent and limited to once a year.

Read more from CNNMoney.